Rheumatic Manifestations in Malignancy
Journal:
Current Rheumatology Reviews
Volume:
4
Page:
50-58
Author(s):
Eric L. Matteson and Mohannad A. Abu-Hilal
Malignancy Risk in Systemic Lupus: Recent Research and Ongoing Challenges
Journal:
Current Rheumatology Reviews
Volume:
4
Page:
59-62
Author(s):
Sasha Bernatsky, Rosalind Ramsey-Goldman and Ann E. Clarke
Apoptosis in the Homeostasis of the Immune System and in Human Immune Mediated Diseases
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
253-268
Author(s):
R. Paganelli, A. Giovannetti, M. Pierdominici, A. Di Iorio, R. Cianci, G. Murdaca, F. Puppo and F. Pandolfi
Pharmacokinetic Properties of Rituximab
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
22-30
Author(s):
Jose Rodriguez and Antonio Gutierrez
Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
3
Page:
20-30
Author(s):
Ramzi Mohammad, Anshu Giri and Anton-Scott Goustin
Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
22-29
Author(s):
Petar M. Mitrasinovic and Marija L. Mihajlovic
Inhibitors of the Ubiquitin-Proteasome System and the Cell Death Machinery: How Many Pathways are Activated?
Journal:
Current Molecular Pharmacology
Volume:
1
Page:
24-37
Author(s):
Claudio Brancolini
Human Immunodeficiency Virus-Induced Apoptosis of Human Breast Cancer Cells Via CXCR4 is Mediated by the Viral Envelope Protein But Does Not Require CD4
Journal:
Current HIV Research
Volume:
6
Page:
34-42
Author(s):
Shogo Misumi, Masafumi Endo, Asako Inatsu, Koji Hashimoto, Nobutoki Takamune and Shozo Shoji
Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3622-3636
Author(s):
Kosmas I. Paraskevas, Alexandros A. Tzovaras, Despina D. Briana and Dimitri P. Mikhailidis
Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
373-381
Author(s):
Bjorn Tore Gjertsen, Therese Bredholt, Nina Anensen and Olav Karsten Vintermyr